Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001047323 | SCV001211273 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type R18 | 2022-08-04 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 6 of the TRAPPC11 gene. It does not directly change the encoded amino acid sequence of the TRAPPC11 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs770891745, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with TRAPPC11-related conditions. ClinVar contains an entry for this variant (Variation ID: 844472). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001047323 | SCV003823407 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type R18 | 2022-03-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003317422 | SCV004021826 | uncertain significance | not provided | 2023-01-10 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on splicing; Has not been previously published as pathogenic or benign to our knowledge |
Athena Diagnostics | RCV003317422 | SCV005620466 | uncertain significance | not provided | 2023-12-21 | criteria provided, single submitter | clinical testing |